| 2-Amino-6-chloropyridine |
2-氨基-6-氯吡啶 |
45644-21-1 |
| trans-3-Furanacrylic acid |
trans-3-呋喃丙烯酸 |
81311-95-7 |
| 4-Amino-1-methylpyridin-2(1H)-one |
4-氨基-1-甲基吡啶-乙酮 |
952182-01-3 |
| 7-Octynoic acid, 8-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]- |
CRBN 配体 4 |
2429878-72-6 |
| GLP-1 receptor agonist 1 |
GLP-1 receptor agonist 1 |
2212020-52-3 |
| Pyridine, 4-(3,5-difluorophenyl)- |
4-(3,5-二氟苯基)吡啶 |
1166397-62-1 |
| Pyridine, 4-(2-chlorophenyl)- |
4-(2-氯苯基)吡啶 |
4467-15-6 |
| 1,3-bis(2-chloro-4-(trifluoroMethyl)phenoxy)benzene |
1,3-双(2-氯-4-(三氟甲基)苯氧基)苯 |
50594-74-6 |
| (R)-Flurbiprofen Axetil (Mixture of Diastereomers) |
(R)-氟比洛芬酯(非对映异构体混合物) |
2375240-97-2 |
| 2-Amino-5-iodopyridine |
2-氨基-5-碘吡啶 |
20511-12-0 |
| 2-Pyridinecarboxamide, 4-[[[(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furanyl]carbonyl]amino]- |
SUZETRIGINE |
2649467-58-1 |
| Carbamic acid, N-[5-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]pentyl]-, 1,1-dimethylethyl ester |
CRBN配体1 |
2138441-25-3 |
| 10H-Phenothiazine, 3,7-dinitro- |
3.7-二硝基-10H-吩噻嗪 |
1747-90-6 |
| 10H-Phenothiazine-3,7-diamine, hydrochloride (1:2) |
10H-Phenothiazine-3,7-diamine, hydrochloride (1:2) |
951131-09-2 |
| Morpholinium, 4-[chloro(dimethylamino)methylene]-, hexafluorophosphate(1-) (1:1) |
吗啉,4-[氯(二甲基氨基)亚甲基]-六氟磷酸盐(1-)(1:1) |
958029-35-1 |
| 73421-39-3 |
六氟磷酸氯三(二甲基氨基)鏻 |
73421-39-3 |
| Vortioxetine hydrobromide |
氢溴酸沃替西汀 |
960203-27-4 |
| 3-(Trifluoromethyl)benzoyl chloride |
3-(三氟甲基)苯甲酰氯 |
2251-65-2 |
| 2,4,5-Trichloro Benzotrifluoride |
2,4,5-三氯三氟甲苯 |
56148-83-5 |
| L-Tetrahydrofolic Acid |
四氢叶酸 |
135-16-0 |
QQ
微信
